• Print

In the 2004–05 financial year, asthma expenditure was $606 million (1.2% of the total allocated health expenditure).

The greatest proportion of asthma expenditure was attributable to prescription pharmaceuticals.

Asthma expenditure consisted of:

  • 59% prescription pharmaceuticals (including all pharmaceuticals for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions).
  • 23% out-of-hospital-costs
  • 16% admitted patient costs (including public and private acute hospitals, psychiatric hospitals, and medical services provided to private admitted patients in hospital).
  • 2% research.

Asthma expenditure 2004–05

expenditure

(a) Includes all pharmaceuticals for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions.
(b) Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.

Source: AIHW disease expenditure database as at December 2008.

In the 2004–05 financial year, the area of health expenditure which accounted for most of the costs varied between age groups and sex. For example, for males age 0–4, expenditure on admitted patients with asthma was about 39% of the total expenditure. On the other hand, for males age 65–74 with asthma, expenditure on admitted patients was about 8% of the total expenditure.

expenditure-sex

(a) Includes all pharmaceuticals for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions.
(b) Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.

Source: AIHW disease expenditure database as at December 2008.


Source tables

Direct expenditure allocated to asthma, by type of expenditure, 2004–05
Per cent
Prescription pharmaceuticals (a) 59
Out-of-hospital medical costs 23
Admitted patient costs (b) 16
Research 2

(a) Includes all pharmaceuticals for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions.
(b) Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.

Source: AIHW disease expenditure database as at December 2008.

Allocated expenditure on asthma, by age, sex and area of health expenditure, 2004–05, ($ millions)
Age Male Female
Admitted patients (a) Out-of-hospital medical services Prescription pharmaceuticals (b) Admitted patients (a) Out-of-hospital medical services Prescription pharmaceuticals (b)
0–4 16.765 9.993 16.582 9.096 5.397 9.611
5–14 9.809 11.315 32.856 6.557 7.570 20.703
15–24 2.614 6.093 16.730 4.396 7.505 22.732
25–34 2.170 4.845 12.612 4.646 7.036 20.698
35–44 2.234 5.321 14.608 6.986 7.757 28.379
45–54 2.472 5.276 14.403 6.321 10.879 24.017
55–64 2.223 8.865 18.143 6.645 13.901 28.812
65–74 1.668 3.734 16.756 4.726 10.665 24.417
75–84 1.555 4.301 11.341 5.139 5.109 17.037
85+ 0.274 0.720 2.785 1.814 1.324 4.930

(a) Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.
(b) Includes all pharmaceuticals for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions.

Source: AIHW disease expenditure database as at December 2008.